Primary Mediastinal Large B-cell Lymphoma: Clinical Trials

1 trial for Primary Mediastinal Large B-cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Primary Mediastinal Large B-cell Lymphoma: new trials by email Literature Review of Primary Mediastinal Large B-cell Lymphoma trials Research Report on Primary Mediastinal Large B-cell Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs
Decitabine, GVD chemotherapy, SHR-1210 - Primary Mediastinal Large B-cell Lymphoma
Phase 1 / Phase 2UnknownChinese PLA General Hospital302017-05-012018-12-03

Narrower conditions

Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Decitabine (1)  ·  Immune Checkpoint Inhibitors (1)  ·  camrelizumab (1)

Sponsors

Chinese PLA General Hospital (1)

Countries

China (1)